Tag Archives: Hematology

Four-Drug Mix Treats Multiple Myeloma With Fewer Side Effects

June 6th, 2012 - 5:01 pm

A four-drug combination of chemotherapy drugs scored high marks as a highly effective treatment for patients newly diagnosed with the blood cancer multiple myeloma, according to results from a Mayo Clinic-led study. The multidrug regimen, called CYCLONE (comprised of Cyclophosphamide, … Continue reading →

By susanashephard | Posted in Cancer | Tagged Arizona, CYCLONE, Hematology, Joseph Mikhael, Mayo Clinic, Mikhael, multiple myeloma, Myeloma | Leave a comment

Study Finds Ruxolitinib Effective in Reducing Symptoms for Myelofibrosis Patients

March 1st, 2012 - 11:49 am

For patients diagnosed with myelofibrosis, a bone marrow disorder that disrupts the body’s normal production of blood cells, new hope may be on the horizon. A study, published in the March 1 edition of the New England Journal of Medicine, … Continue reading →

By susanashephard | Posted in Cancer | Tagged Arizona, Hematology, Mayo Clinic, myelofibrosis, Ruben Mesa, Ruxolitinib | Comments (1)

Mayo Collaborative Study: Early Findings Show Promise Against Bone Marrow Disease

September 16th, 2010 - 4:21 pm

Mayo Clinic Cancer Center researchers and collaborators from the M.D. Anderson Cancer Center have found “marked and durable” patient benefits from an experimental drug that inhibits a mutation responsible for myelofibrosis, a serious bone marrow disease that can lead to … Continue reading →

By Robert Nellis | Posted in Cancer | Tagged bone marrow, Hematology, Leukemia, Mayo Clinic Cancer Center, myleofibrosis | Leave a comment

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

October 22nd, 2009 - 3:05 pm

High-dose dexamethasone is a mainstay of therapy for multiple myeloma. However, a study published today online and in the November edition of The Lancet Oncology concludes that lenalidomide plus low-dose dexamethasone is associated with better short-term overall survival and lower … Continue reading →